Theravance Biopharma Inc (TBPH)
R&D Expenses
$25.62M
TTM · Period ending: · USD
TBPH R&D Expenses
Latest reported$25.62Mperiod ending
Latest reported$25.62Mperiod ending
TBPH TTM R&D Expenses ($120.58M → $25.62M)
TTM R&D Expenses
High-resolution chart · PNG
TBPH r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 25,616,000 | |
| 31,394,000 | |
| 37,017,000 | |
| 39,429,000 | |
| 40,585,000 | |
| 40,049,000 | |
| 37,565,000 | |
| 37,185,000 | |
| 35,796,000 | |
| 37,214,000 | |
| 44,571,000 | |
| 52,870,000 | |
| 56,515,000 | |
| 61,609,999 | |
| 70,073,999 | |
| 85,909,999 | |
| 121,425,999 | |
| 157,312,000 | |
| 201,548,000 | |
| 237,865,000 | |
| 258,196,000 | |
| 268,247,000 | |
| 265,235,000 | |
| 262,813,000 | |
| 247,448,000 | |
| 231,443,000 | |
| 219,248,000 | |
| 204,492,000 | |
| 205,179,000 | |
| 207,401,000 | |
| 201,348,000 | |
| 200,130,000 | |
| 186,780,000 | |
| 181,086,000 | |
| 173,886,000 | |
| 164,848,000 | |
| 157,456,000 | |
| 146,598,000 | |
| 141,711,000 | |
| 132,100,000 | |
| 130,516,000 | |
| 128,824,000 | |
| 129,165,000 | |
| 138,955,000 | |
| 146,912,000 | |
| 162,818,000 | |
| 168,522,000 | |
| 158,800,000 | |
| 152,777,000 | |
| 136,894,000 | |
| 120,579,000 | |
| 116,245,000 | |
| 110,033,000 |